Letter to Editor
BibTex RIS Cite

Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis

Year 2019, , 233 - 235, 04.01.2019

Hilmi Erdem Sümbül , Onur Taktakoğlu

https://doi.org/10.18621/eurj.389830

Abstract

No abstract available.

Keywords

plasmapheresis rituximab thrombotic microanjiopathy

References

  • [1] George JN. How I treat patients with thrombotic thrombocytopenic purpura:2010. Blood 2010;116:4060-9.
  • [2] Kremer Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN. Survival and relapse in patient with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-11.
  • [3] George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher 2006;21:49-56.
  • [4] Ling HT, Field JJ, Blinder MA. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Am J Hematol 2009;84:418-21.
  • [5] McDonald V, Manns K, Mackie IJ, Machin SJ, Scully MA. Rituximab pharmakonetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J Thromb Haemost 2010;8:1201-8.

Year 2019, , 233 - 235, 04.01.2019

Hilmi Erdem Sümbül , Onur Taktakoğlu

https://doi.org/10.18621/eurj.389830

Abstract

References

  • [1] George JN. How I treat patients with thrombotic thrombocytopenic purpura:2010. Blood 2010;116:4060-9.
  • [2] Kremer Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN. Survival and relapse in patient with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-11.
  • [3] George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher 2006;21:49-56.
  • [4] Ling HT, Field JJ, Blinder MA. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Am J Hematol 2009;84:418-21.
  • [5] McDonald V, Manns K, Mackie IJ, Machin SJ, Scully MA. Rituximab pharmakonetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J Thromb Haemost 2010;8:1201-8.
There are 5 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Letters to the Editor
Authors

Hilmi Erdem Sümbül 0000-0002-7192-0280

Onur Taktakoğlu This is me 0000-0002-9017-7760

Publication Date January 4, 2019
Submission Date February 3, 2018
Acceptance Date June 1, 2018
Published in Issue Year 2019

Cite

AMA Sümbül HE, Taktakoğlu O. Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis. Eur Res J. January 2019;5(1):233-235. doi:10.18621/eurj.389830

e-ISSN: 2149-3189 


The European Research Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png

2025